ilShinbiobase Co. Ltd (068330) — Cash Flow-to-Debt Ratio
ilShinbiobase Co. Ltd (068330) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2026, meaning its operating cash flow of ₩426.36 Million could theoretically repay 0% of its total liabilities (₩6.72 Billion) in one year. Check 068330 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ilShinbiobase Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for ilShinbiobase Co. Ltd across 12 annual periods. Check 068330 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow-to-Debt Ratio for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for ilShinbiobase Co. Ltd. For the full cash flow conversion analysis, see how efficiently does ilShinbiobase Co. Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.39x | ₩5.27 Billion | ₩3.79 Billion | ▲ +17.7% |
| 2024 | 1.18x | ₩4.12 Billion | ₩3.49 Billion | ▼ -29.2% |
| 2023 | 1.67x | ₩5.92 Billion | ₩3.55 Billion | ▲ +191.7% |
| 2022 | 0.57x | ₩2.65 Billion | ₩4.63 Billion | ▼ -46.1% |
| 2021 | 1.06x | ₩6.74 Billion | ₩6.36 Billion | ▲ +21.8% |
| 2020 | 0.87x | ₩4.50 Billion | ₩5.17 Billion | ▼ -14.2% |
| 2019 | 1.01x | ₩5.55 Billion | ₩5.47 Billion | ▼ -20.6% |
| 2018 | 1.28x | ₩4.88 Billion | ₩3.81 Billion | ▲ +97.7% |
| 2017 | 0.65x | ₩2.11 Billion | ₩3.27 Billion | ▲ +0.5% |
| 2016 | 0.64x | ₩3.01 Billion | ₩4.68 Billion | ▲ +1162.0% |
| 2015 | 0.05x | ₩270.22 Million | ₩5.30 Billion | ▼ -94.0% |
| 2014 | 0.85x | ₩3.33 Billion | ₩3.93 Billion | — |